Heparin blocks transfer of extracellular vesicles between donor and recipient cells

被引:160
作者
Atai, Nadia A. [1 ,2 ,3 ,4 ]
Balaj, Leonora [1 ,2 ,3 ]
van Veen, Henk [4 ]
Breakefield, Xandra O. [3 ,5 ]
Jarzyna, Peter A.
Van Noorden, Cornelis J. F. [4 ]
Skog, Johan
Maguire, Casey A. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Program Neurosci, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
[4] Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Massachusetts Gen Hosp, Dept Neurol & Radiol, Boston, MA 02114 USA
关键词
Extracellular vesicles; Exosomes; Glioblastoma; EGFRvIII; Heparin; Tumor; CANCER; EXOSOMES; ANTICOAGULANTS; PROGRESSION; BIOGENESIS; SURVIVAL; DELIVERY; SYSTEM; GROWTH; TUMORS;
D O I
10.1007/s11060-013-1235-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extracellular vesicles (EVs) have been implicated in tumorigenesis. Biomolecules which can block EV binding and uptake into recipient cells may be of therapeutic value as well as enhance understanding of EV biology. Here, we show that heparin interacts with uptake of tumor-derived as well as non-tumor-derived EVs into recipient cells. Incubation of glioma cell-derived EVs with heparin resulted in micron-sized structures observed by transmission electron microscopy, with EVs clearly visible within these structures. Inclusion of heparin greatly diminished transfer of labeled EVs from donor to recipient tumor cells. We also show a direct interaction between heparin and EVs using confocal microscopy. We found that the block in EV uptake was at the level of cell binding and not internalization. Finally, incubation of glioma-derived EVs containing EGFRvIII mRNA with heparin reduced transfer of this message to recipient cells. The effect of heparin on EVs uptake may provide a unique tool to study EV function. It may also foster research of heparin or its derivatives as a therapeutic for disease in which EVs play a role.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 30 条
  • [1] Microvesicles Messengers and mediators of tumor progression
    Al-Nedawi, Khalid
    Meehan, Brian
    Rak, Janusz
    [J]. CELL CYCLE, 2009, 8 (13) : 2014 - 2018
  • [2] Syndecan-syntenin-ALIX regulates the biogenesis of exosomes
    Baietti, Maria Francesca
    Zhang, Zhe
    Mortier, Eva
    Melchior, Aurelie
    Degeest, Gisele
    Geeraerts, Annelies
    Ivarsson, Ylva
    Depoortere, Fabienne
    Coomans, Christien
    Vermeiren, Elke
    Zimmermann, Pascale
    David, Guido
    [J]. NATURE CELL BIOLOGY, 2012, 14 (07) : 677 - 685
  • [3] Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences
    Balaj, Leonora
    Lessard, Ryan
    Dai, Lixin
    Cho, Yoon-Jae
    Pomeroy, Scott L.
    Breakefield, Xandra O.
    Skog, Johan
    [J]. NATURE COMMUNICATIONS, 2011, 2
  • [4] Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis
    Borsig, L
    Wong, R
    Feramisco, J
    Nadeau, DR
    Varki, NM
    Varki, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) : 3352 - 3357
  • [5] The potential of exosomes in immunotherapy
    Chaput, N
    Taïeb, J
    André, F
    Zitvogel, L
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (06) : 737 - 747
  • [6] Human tumor-derived exosomes selectively impair lymphocyte responses to interieukin-2
    Clayton, Aled
    Mitchell, J. Paul
    Court, Jacquelyn
    Mason, Malcolm D.
    Tabi, Zsuzsanna
    [J]. CANCER RESEARCH, 2007, 67 (15) : 7458 - 7466
  • [7] CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
    Dolecek, Therese A.
    Propp, Jennifer M.
    Stroup, Nancy E.
    Kruchko, Carol
    [J]. NEURO-ONCOLOGY, 2012, 14 : v1 - v49
  • [8] Engelberg H, 1999, CANCER-AM CANCER SOC, V85, P257, DOI 10.1002/(SICI)1097-0142(19990115)85:2<257::AID-CNCR1>3.0.CO
  • [9] 2-2
  • [10] Gerotziafas GT, 2008, PATHOPHYSIOL HAEMO T, V36, P204